Revolution Medicines RVMD Chief Financial Officer · filings 2020 to 2026 · sold $10.8M · $9.6M noticed on Form 144
| Date | Transaction | Shares | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sale under a 10b5-1 plan | −61 | $195.00 | $12K | 123,208 direct | Filing · EDGAR |
| Sep 16, 2026 | Sale under a 10b5-1 plan | −3,992 | $199.30 | $796K | 119,216 direct | Filing · EDGAR |
| Jun 24, 2026 | Option or RSU exercised or converted | +20,000 | $18.56 | $371K | 143,269 direct | Filing · EDGAR |
| Jun 24, 2026 | Sale under a 10b5-1 plan | −4,553 | $167.35 | $762K | 138,716 direct | Filing · EDGAR |
| Jun 24, 2026 | Sale under a 10b5-1 plan | −9,496 | $168.20 | $1.6M | 129,220 direct | Filing · EDGAR |
| Jun 24, 2026 | Sale under a 10b5-1 plan | −5,651 | $169.24 | $956K | 123,569 direct | Filing · EDGAR |
| Jun 24, 2026 | Sale under a 10b5-1 plan | −300 | $170.32 | $51K | 123,269 direct | Filing · EDGAR |
| Jun 24, 2026 | Option or RSU exercised or converted Stock Option (Right to Buy) | +20,000 | 20,600 direct | Filing · EDGAR | ||
| Jun 16, 2026 | Sale under a 10b5-1 plan | −2,722 | $156.12 | $425K | 123,269 direct | Filing · EDGAR |
| Mar 17, 2026 | Sale under a 10b5-1 plan | −2,753 | $99.48 | $274K | 125,512 direct | Filing · EDGAR |
| Mar 1, 2026 | Grant or award from the company | +20,200 | 128,265 direct | Filing · EDGAR | ||
| Mar 1, 2026 | Grant or award from the company Stock Option (Right to Buy) | +45,400 | 45,400 direct | Filing · EDGAR | ||
| Jan 7, 2026 | Option or RSU exercised or converted | +10,000 | $42.45 | $425K | 118,065 direct | Filing · EDGAR |
| Jan 7, 2026 | Sale under a 10b5-1 plan | −10,000 | $98.00 | $980K | 108,065 direct | Filing · EDGAR |
| Jan 7, 2026 | Option or RSU exercised or converted Stock Option (Right to Buy) | −10,000 | 15,900 direct | Filing · EDGAR | ||
| Dec 16, 2025 | Sale under a 10b5-1 plan | −3,104 | $77.09 | $239K | 108,065 direct | Filing · EDGAR |
| Nov 25, 2025 | Option or RSU exercised or converted | +5,418 | $17.00 | $92K | 116,412 direct | Filing · EDGAR |
| Nov 25, 2025 | Sale under a 10b5-1 plan | −5,418 | $74.00 | $401K | 110,994 direct | Filing · EDGAR |
| Nov 25, 2025 | Option or RSU exercised or converted Stock Option (Right to Buy) | −5,418 | 0 direct | Filing · EDGAR | ||
| Nov 11, 2025 | Option or RSU exercised or converted | +10,000 | $17.00 | $170K | 120,994 direct | Filing · EDGAR |
| Nov 11, 2025 | Sale under a 10b5-1 plan | −10,000 | $64.00 | $640K | 110,994 direct | Filing · EDGAR |
| Nov 11, 2025 | Option or RSU exercised or converted Stock Option (Right to Buy) | −10,000 | 5,418 direct | Filing · EDGAR | ||
| Sep 16, 2025 | Sale under a 10b5-1 plan | −2,320 | $45.82 | $106K | 110,994 direct | Filing · EDGAR |
| Sep 3, 2025 | Option or RSU exercised or converted | +3,189 | $4.73 | $15K | 116,503 direct | Filing · EDGAR |
| Sep 3, 2025 | Option or RSU exercised or converted | +2,049 | $17.00 | $35K | 118,552 direct | Filing · EDGAR |
| Sep 3, 2025 | Sale under a 10b5-1 plan | −5,238 | $40.17 | $210K | 113,314 direct | Filing · EDGAR |
| Sep 3, 2025 | Option or RSU exercised or converted Stock Option (Right to Buy) | −3,189 | 0 direct | Filing · EDGAR | ||
| Sep 3, 2025 | Option or RSU exercised or converted Stock Option (Right to Buy) | −2,049 | 15,418 direct | Filing · EDGAR | ||
| Sep 2, 2025 | Option or RSU exercised or converted | +2,814 | $2.68 | $8K | 116,128 direct | Filing · EDGAR |
| Sep 2, 2025 | Option or RSU exercised or converted | +1,948 | $4.73 | $9K | 118,076 direct | Filing · EDGAR |
| Sep 2, 2025 | Sale under a 10b5-1 plan | −4,762 | $40.02 | $191K | 113,314 direct | Filing · EDGAR |
| Sep 2, 2025 | Option or RSU exercised or converted Stock Option (Right to Buy) | −2,814 | 0 direct | Filing · EDGAR | ||
| Sep 2, 2025 | Option or RSU exercised or converted Stock Option (Right to Buy) | −1,948 | 3,189 direct | Filing · EDGAR | ||
| Jun 16, 2025 | Sale under a 10b5-1 plan | −2,170 | $39.83 | $86K | 113,314 direct | Filing · EDGAR |
| Mar 17, 2025 | Sale under a 10b5-1 plan | −1,864 | $39.04 | $73K | 115,006 direct | Filing · EDGAR |
| Mar 1, 2025 | Grant or award from the company | +20,400 | 116,870 direct | Filing · EDGAR | ||
| Mar 1, 2025 | Grant or award from the company Stock Option (Right to Buy) | +71,400 | 71,400 direct | Filing · EDGAR | ||
| Dec 16, 2024 | Sale under a 10b5-1 plan | −2,635 | $45.40 | $120K | 96,470 direct | Filing · EDGAR |
| Oct 11, 2024 | Option or RSU exercised or converted | +10,000 | $2.68 | $27K | 108,932 direct | Filing · EDGAR |
| Oct 11, 2024 | Sale under a 10b5-1 plan | −10,000 | $50.30 | $503K | 98,932 direct | Filing · EDGAR |
| Oct 11, 2024 | Option or RSU exercised or converted Stock Option (Right to Buy) | −10,000 | 2,814 direct | Filing · EDGAR | ||
| Sep 16, 2024 | Sale under a 10b5-1 plan | −2,244 | $44.19 | $99K | 98,932 direct | Filing · EDGAR |
| Jun 17, 2024 | Sale under a 10b5-1 plan | −1,893 | $37.39 | $71K | 101,176 direct | Filing · EDGAR |
| May 3, 2024 | Option or RSU exercised or converted | +10,000 | $2.68 | $27K | 111,959 direct | Filing · EDGAR |
| May 3, 2024 | Sale under a 10b5-1 plan | −10,000 | $40.03 | $400K | 101,959 direct | Filing · EDGAR |
| May 3, 2024 | Option or RSU exercised or converted Stock Option (Right to Buy) | −10,000 | 12,814 direct | Filing · EDGAR | ||
| Mar 18, 2024 | Sale under a 10b5-1 plan | −1,261 | $31.58 | $40K | 101,959 direct | Filing · EDGAR |
| Mar 1, 2024 | Grant or award from the company | +26,400 | 103,220 direct | Filing · EDGAR | ||
| Mar 1, 2024 | Grant or award from the company Stock Option (Right to Buy) | +92,400 | 92,400 direct | Filing · EDGAR | ||
| Dec 18, 2023 | Sale under a 10b5-1 plan | −1,775 | $25.90 | $46K | 76,416 direct | Filing · EDGAR |
| Oct 23, 2023 | Option or RSU exercised or converted | +19,387 | $2.68 | $52K | 73,054 direct | Filing · EDGAR |
| Oct 23, 2023 | Option or RSU exercised or converted | +5,137 | $4.09 | $21K | 78,191 direct | Filing · EDGAR |
| Oct 23, 2023 | Option or RSU exercised or converted Stock Option (Right to Buy) | −19,387 | 22,814 direct | Filing · EDGAR | ||
| Oct 23, 2023 | Option or RSU exercised or converted Stock Option (Right to Buy) | −5,137 | 0 direct | Filing · EDGAR | ||
| Sep 18, 2023 | Open-market or private sale | −1,427 | $31.31 | $45K | 53,667 direct | Filing · EDGAR |
| Sep 1, 2023 | Option or RSU exercised or converted | +20,000 | $2.68 | $54K | 75,094 direct | Filing · EDGAR |
| Sep 1, 2023 | Sale under a 10b5-1 plan | −20,000 | $35.05 | $701K | 55,094 direct | Filing · EDGAR |
| Sep 1, 2023 | Option or RSU exercised or converted Stock Option (Right to Buy) | −20,000 | 42,201 direct | Filing · EDGAR | ||
| Jun 20, 2023 | Open-market or private sale | −1,249 | $24.89 | $31K | 55,094 direct | Filing · EDGAR |
| Mar 17, 2023 | Open-market or private sale | −665 | $21.78 | $14K | 55,233 direct | Filing · EDGAR |
22 earlier transactions are in the filing list below.
